The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer

Targeting cuproplasia and cuproptosis in cancer

Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis

Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer